Nestle's Atrium Adds LivingMatrix As New Cog In Personalized Health Strategy

Atrium expects to scale its nutrition personalization services by integrating LivingMatrix with its PureGenomics platform, which combines educational tools, protocols and core products with a practitioner website application to help identify and address single nucleotide polymorphisms.

Matrix and Atrium logos
LivingMatrix joins Atrium Innovations as a business owned by Nestle Health Science.

More from Deals

KKR Expands Health & Beauty Portfolio With Deal For Sweden’s Karo

 
• By 

Consumer health player Karo is changing hands from EQT to KKR in a deal thought to value the Stockholm-based firm at over €2.5bn.

Clasado Divests Bimuno Prebiotic Consumer Brand To UK’s Eleat

 
• By 

Eleat's acquisition encompasses Clasado's Bimuno finished supplement product line and customer base, but not its Bimuno GOS proprietary galactooligosaccharide prebiotic ingredient.

Schwabe Taps Into Younger Audience With Braineffect Deal

 
• By 

By taking a majority stake in dynamic dietary supplements firm Braineffect, Germany's Schwabe can reach a new, younger target audience for its OTC herbal medicines.

Herbalife Spends To Add Personalized Supplements Through Nutrition App, Enter Ketone Market

 

Direct seller has deals to fully acquire and 51% ownership of Link BioSciences, which formulates personalized supplements. It also announced a deal to acquire Pruvit Ventures, ketone supplements direct seller.

More from Business

Givaudan Has UTI Health Claim Turned Down In EU

 
• By 

European Food Safety Authority finds no cause and effect relationship between Givaudan's Pacran supplement and defense against urinary tract infections.

‘The Only Certainty Is Uncertainty’ In The UK’s Consumer Health Market

 
• By 

While uncertainty might reign in the UK consumer health market - which grew by by 8% to £4.1bn ($5.3bn) in 2024 - “opportunity is everywhere” according to NielsenIQ health and beauty insights manager Alex Heffernan.

ProBiotix Health Looks To Next Level In Korea’s $450m Probiotics Market

 
• By 

Agreement with Seoul-based health and wellness player TopHealth will see the roll out of ProBiotix' cholesterol-lowering probiotics in South Korea.